Feasibility and Efficacy of the AveCure Flexible Microwave Ablation Probe for Peripheral Lung Nodule
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This research study to determine the effectiveness of the AveCure Flexible Microwave Ablation Probe to destroy cancerous lung nodules up to 3 c m in size. This research study involves microwave ablation (MWA)
Eligibility
Participation Requirements
Sex: All
Minimum Age: 22
Healthy Volunteers: f
View:
• Subject with Stage I - II primary lung cancer (Solitary nodules up to 3 cm) as defined by previous pathology or ROSE.
• Pathological proof of target nodule/tumor type and malignancy with specimen considered adequate per institutional laboratory standards
• Target nodule/tumor which can be accessed via navigational bronchoscopy and confirmed location with cone beam CT scan intra-operatively
• Resection/surgical candidate (lobectomy or greater)
• Participants must be at least 22 years old and able to provide consent
Locations
United States
Massachusetts
Beth Israel Deaconess Medical Center
RECRUITING
Boston
Contact Information
Primary
Jason Beattie, MD
jbeattie@bidmc.harvard.edu
(617) 632- 8252
Time Frame
Start Date: 2022-06-01
Estimated Completion Date: 2027-06-30
Participants
Target number of participants: 10
Treatments
Experimental: AVECURE FLEXIBLE MICROWAVE ABLATION PROBE FOR LUNG NODULES
The research study procedures include screening for eligibility and study treatment including evaluations and follow up visits.~* Ablation Procedure- MWA will be used to treat solitary pulmonary nodules up to 3cm.~* CT scan will then be performed to evaluate the radiological changes 2 - 4 weeks after the ablation procedure.~* Surgery will be performed to remove the lung nodule and the tissue will be evaluated by pathology.
Authors
Related Therapeutic Areas
Sponsors
Collaborators: Dana-Farber Cancer Institute, MedWaves, Inc
Leads: Beth Israel Deaconess Medical Center